How to appeal a Blue Cross Blue Shield of Massachusetts neuropsychological & psychological testing — adhd, tbi, dementia, asd, presurgical eval denial

The framework that applies to your appeal

Federal law gives you the right to a full and fair internal appeal, then an external review by an independent third party.

Blue Cross Blue Shield of Massachusetts-specific note: Non-profit; ~3M members. MA has the most expansive state mandated benefits in the US and strong supplemental parity rules. MA OPP (Office of Patient Protection) provides external review separately from carriers — distinct from federal IRO process for fully-insured plans.

What Blue Cross Blue Shield of Massachusetts's policy requires for neuropsychological & psychological testing — adhd, tbi, dementia, asd, presurgical eval

Cited policy: BCBS medical policy Neuropsychological Testing + Anthem clinical guideline Psychological and Neuropsychological Testing

DSM-5-TR ASD criteria considered; multi-method evaluation per APA Specialty Guidelines; ADOS-2 + ADI-R + cognitive + adaptive testing as gold standard.

How Blue Cross Blue Shield of Massachusetts denies neuropsychological & psychological testing — adhd, tbi, dementia, asd, presurgical eval — and how to counter it

Where Blue Cross Blue Shield of Massachusetts pushes back: 1) 'Comprehensive battery excessive — clinical interview adequate'; 2) 'ASD already diagnosed by pediatrician'; 3) Hours/CPT codes denied for multi-method approach.

Counter-arguments that hold up: ADOS-2 + ADI-R are NIMH/CPEA-endorsed gold standard for ASD diagnosis and are required by school IEP teams + state developmental services + most early-intervention programs. Without standardized comprehensive eval, downstream services (ABA, speech, OT, IEP) cannot be authorized. APA Specialty Guidelines for Clinical Neuropsychology + DSM-5-TR criteria require multi-method assessment. Submit referral with explicit statement of services to be triggered by diagnosis. ERISA MHPAEA parity argument applies.

What Blue Cross Blue Shield of Massachusetts typically denies for neuropsychological & psychological testing — adhd, tbi, dementia, asd, presurgical eval

Across Blue Cross Blue Shield of Massachusetts's commercial and Medicare books, denials cluster around a small number of patterns. For neuropsychological & psychological testing — adhd, tbi, dementia, asd, presurgical eval, expect:

• MA-specific mandated benefit disputes (most generous in US)
• Behavioral health parity (MA has tighter parity rules than federal MHPAEA)
• Tiered-network provider disputes
• Specialty drug PA

Treatments most often denied in this category

These are the neuropsychological & psychological testing — adhd, tbi, dementia, asd, presurgical eval treatments most often flagged for prior auth, step therapy, or medical necessity review:

• Comprehensive neuropsych battery
• ADHD neuropsych eval
• Post-concussion / mTBI eval
• Moderate-severe TBI eval
• Dementia workup
• ASD diagnostic eval

How to submit the appeal to Blue Cross Blue Shield of Massachusetts

1. Read the denial letter — note the exact denial reason code and the appeal deadline (180 days from the date on the letter).
2. Gather supporting documentation: physician letter of medical necessity, relevant clinical notes, peer-reviewed citations supporting the treatment for your indication, and the policy or coverage document Blue Cross Blue Shield of Massachusetts cited in the denial.
3. File the appeal through Blue Cross Blue Shield of Massachusetts's portal (members: https://home.bluecrossma.com ; providers: https://provider.bluecrossma.com). Standard decision returns within 30 days; expedited urgent appeals return within 72 hours.
4. If denied again, request external review by an independent reviewer within 4 months of the final internal denial. In MA, the state insurance department coordinates external review for fully-insured plans; ERISA self-funded plans use a federal external review through DOL/EBSA.

Clinician or prior-auth team handling this on the practice side? See Blue Cross Blue Shield of Massachusetts's prior-authorization criteria by drug: Blue Cross Blue Shield of Massachusetts PA criteria on ApprovalHelp.